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Abstract: Background: Insulin resistance is a frequent metabolic disorder in Polycystic 
Ovary Syndrome (PCOS). Moringa oleifera has been shown to increase insulin expres-
sion and decrease the degree of insulin in diabetes mellitus, therefore it is expected that 
Moringa oleifera could decrease insulin levels and increase folliculogenesis in PCOS. 
Objective: To prove the effect of Moringa oleifera leaf extract in various doses might de-
crease the insulin levels and increase folliculogenesis in female PCOS-insulin resistant 
rats. 
Methods: The three month old white rat of Wistar strain (Rattus norvegicus) 100-130 
grams were divided into five groups (n=8) including normal control, PCOS-insulin resis-
tance, PCOS-insulin resistance given metformin and PCOS-resistance insulin were given 
Moringa oleifera leaf extract in two doses. Then, the PCOS model-insulin resistance by 
injection of testosterone propionate for 28 days. After 14 days treatment, we analysed in-
sulin levels and folliculogenesis. 
Results: The PCOS control group showed a significant increase in insulin levels com-
pared to the normal control group. The insulin levels from group treatment with Moringa 
oleifera leaf extract of 250 mg/kgBW was significantly lower than the PCOS control 
group. Ovarian histology analysis found that the number and diameter of follicle of 
PCOS control group showed a significant decrease compared to normal control group. In 
addition, the treatment with metformin and leaf Moringa oleifera dose 250 mg/kgBW and 
500 mg/kgBW showed significant increase of folliculogenesis compared to PCOS control 
group. 
Conclusions: Moringa oleifera could lowering the blood insulin levels, subsequently 
decreasing the androgen thus allowed the increasing of folliculogenesis in PCOS.
Keywords: Polycystic ovary syndrome, Moringa oleifera, insulin, folliculogenesis, diabetes, testosterone.
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1. INTRODUCTION 
Polycystic Ovary Syndrome (PCOS) is an en-
docrine-metabolic disorder that has severe conse-
quences for women's health that including the of 
infertility [1]. Polycystic ovary syndrome occurs in 
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women of reproductive age, which is 6-10% based 
on US NIH criteria and reaches as high as 15% 
using Rotterdam Criteria 2003 [2]. According to 
the NHMRC results in 2015, a PCOS prevalence 
of 12-21% of women of reproductive age in Aus-
tralia is based on ESHRE/ Rotterdam criteria 
2003. 
PCOS is a disorder of heterogeneous, multifac-
torial, genetic and endocrine complexes [1]. PCOS 
based on ESHRE/Rotterdam Criteria 2003 is diag-
nosed if the two of following three criteria are pre-
sent: polycystic ovary, oligoovulation/anovulation 
or clinical or biochemical evidence of hyperandro-
genism [2]. The etiology and the exact pathogene-
sis of this disorder could not be ascertained, but in 
some further studies, it is agreed that this disorder 
is genetically influenced by the autosomal domi-
nant mode of inheritance (mainly from the paternal 
origin) [3]. PCOS pathogenesis includes abnormal 
gonadotropin secretion, abnormal steroidogenesis, 
insulin resistance, p450c17 and genetic dysregula-
tion [4]. Insulin resistance (71%) is the most 
common metabolic abnormality in PCOS with the 
incidence of metabolic syndrome (31.5%) [5]. In-
sulin resistance leads to hyperinsulinemia compen-
sation, increased androgen production in the ova-
ries by increasing GnRH frequency and LH pulsa-
tion secretion. Insulin and IGF-I are responsible 
for disrupting ovulation. Insulin and IGF-1 indi-
rectly could also increase androgen levels by de-
creasing SHBG production in the liver and sup-
pressing IGFBP-1 synthesis directly, rapidly and 
completely in both the liver and ovaries so that 
IGF-I, IGF-II and testosterone levels are free in-
creased. This increases the long-term risk of type 2 
diabetes mellitus and cardiovascular disease [1]. 
This excessive androgen production also disrupts 
folliculogenesis resulting in menstrual disorders 
and the development of multiple ovarian cysts [6]. 
Metformin is the first line of PCOS obese 
treatment by inhibiting hepatic glucose absorption, 
increasing peripheral glucose uptake, reducing pe-
ripheral insulin levels, and improving GLUT-4. 
However, clinically, finding long-term metformin 
treatment results with indigestion, diarrhea, and 
other effects [7]. Metformin treatment might not 
be suitable as a long-term PCOS treatment. 
Herbal therapy became one of the alternative 
treatments that are being developed in the wider 
community, one of it is Maringa oleifera, a food 
plant originating from India which grows in every 
tropical and subtropical region with temperatures 
around 25-35°C. Food plants are considered rela-
tively safe as they are likely to contain synergistic 
and/or side effect neutralizing combinations of ac-
tivities [8]. Moringa oleifera, known to be rich in 
multiple medicinally active chemicals, may be a 
good candidate to see if it contains effect enhanc-
ing and/or side-effects neutralizing combinations. 
Medicinal plants are relatively rich in their con-
tents of calcium channel blockers (CCBs) which 
are known to possess a wide variety of pharmacol-
ogical activities. But, it remains to be seen whether 
Moringa oleifera have a direct link with the pres-
ence of calcium channel blockers [9]. Recent stud-
ies of Moringa oleifera have potential as antioxi-
dants, anticancer, anti-inflammatory, antidiabetic, 
and as antimicrobial agents [10]. Flavonol quer-
cetin was found with high concentrations in Mor-
inga oleifera leaves [10]. The largest content in 
Moringa oleifera leaf is quercetin known as 
3,3',4',5,7-pentahydroxyflavone (chemical name: 
4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl) 
-3,5,7-trihydroxy-flavone; chemical formula: 
C15H10O7) [11]. Quercetin is one of the flavon-
oids possessing a strong bioactive element with the 
effects of free radicals, anti-inflammation, antican-
cer, antihiperlipidemia, and antiplatelet [12]. Re-
cent studies suggest quercetin is also found to pro-
duce PI3K inhibin [13]. Quercetin PI3K inhibin 
decreases the expression of the CYP17A1 gene in 
theca cells that might be responsible for decreasing 
the activation of 17a-hydroxylase which plays an 
important role in PCOS [14]. In addition, a study 
aimed at assessing the effect of quercetin on ex-
perimental animal PCOS models showed that 
quercetin significantly decreased the insulin levels, 
testosterone and LH levels, and also lipid profile 
[14]. Furthermore, Quercetin also decreases the 
ovarian and uterine weight and increases normal 
follicular and corpus luteum levels in PCOS model 
animals [14].  
In this study, we aimed to perform a research 
by giving a Moringa oleifera which could lower 
the insulin levels in the blood, then be followed by 
decrease of androgen levels. It will improve the 
process of aromatization from androgen hormones 
into estrogens that finally will improve the follicu-
logenesis in experimental models of PCOS. 
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2. MATERIALS AND METHODS 
2.1. Plant Material 
Moringa oleifera or Moringa is a family of 
Moringaceas. This plant is widely grown in tropi-
cal climates such as Indonesia in the lowlands that 
height of 700 meters above sea level. The extract 
of Moringa oleifera leaf (Kelorina, Moringa Or-
ganic Indonesia, Blora, Indonesia) has been pow-
der-shaped and all the processes done according to 
the standard for obtaining the Moringa oleifera 
leaf extract [15]. 
2.2. Animals and Experimental Protocol 
The female rat of Rattus norvegicus strain Wis-
tar (Biochemistry Laboratory, Faculty of Medi-
cine, Airlangga University, Surabaya, Indonesia) 
was 3 months old and weighed 100-130 grams 
[16]. Before the study began, it gives the period of 
adaptation for a week, in healthy condition, in 
normal behavior and the results of normal vaginal 
swab. We excluded rat with anatomical abnormali-
ties and in pregnant during the adaptation. All pro-
cedures described were approved by the ethics 
committee of the Faculty of Veterinary Medicine 
of Airlangga University. 
2.3. Treatment Protocol and Blood Collection 
Time Points 
The female rat Rattus norvegicus Wistar strains 
were randomly divided into five groups (n = 8): 
the normal control group was given aquades for 14 
days, PCOS control group-insulin resistance re-
ceived testosterone propionate injection (Testo-
hormon, Wonderindo Pharmatama, Jakarta, Indo-
nesia) 1 mg/100gBW, intramuscular, in the thigh 
for 28 days to obtain the PCOS model-insulin re-
sistance and aquades as the treatment. While, 
PCOS-insulin resistance rat in metformin group 
received metformin (2mg/100gBW, orally) for 14 
days, and the two treatment groups which used rat 
with PCOS-insulin resistance received treatment 
with oral Moringa oleifera leaf extract (250 
mg/kgBW) and (500 mg/kgBW) for 14 days. Be-
fore and after the study period, we performed va-
gina swab to determine the cycle before and after 
the study.  
2.4. Estimation of Serum Insulin Parameters 
Before the animal was being sacrificed, 12 
hours fasting blood was taken to analyze insulin 
levels and then stored at -20°C until the analysis 
was performed. The serum samples were analyzed 
for insulin levels by using the Enzyme Linked 
Immunosorbent Assay/ELISA kit (Elabscience 
Biotechnology Inc., Wuhan, China) conducted at 
the laboratory of the Institute of Tropical Disease 
Airlangga University. 
2.5. Estimation of Histological Parameters 
Ovarian was removed to measure the folliculo-
genesis and stored in 10% formalin for fixation. 
After fixation, ovarian organs were cut a thickness 
of 0.5 cm, dehydrated and paraffin blocks were 
performed. Slicing with a thickness of 5-7 m 
mounted on the glass object and colored by using 
hematoxylin-eosin. Histopathologic slides were 
observed under a microscope to see the number 
and diameter of primordial follicles, primary, 
secondary, tertiary, also de Graaf. 
2.6. Statistical Analysis 
Normality test using Shapiro-Wilk test. All re-
sults were statistically analyzed using SPSS statis-
tical software package version 18.0 (SPSS, Inc., 
Chicago, IL). One-way factorial analysis of 
ANOVA variance or Kruskal-Wallis Test were 
performed based on the distribution data. The data 
were considered statistically significant at value  
p < 0.05. 
3. RESULTS 
We conducted vaginal swab examination before 
and after the treatment. Vaginal swab before 
treatment showed that the female Rattus 
nervegicus was in the estrous cycle, suggesting in 
the normal reproduction phase. Subsequently, they 
testosterone propionate injections for PCOS-
insulin resistance models. In contrast, vaginal 
swab after treatment mostly on the diestrus cycle 
(Fig. 1). 
3.1. Effect of Treatment on Physical Parame-
ters 
The PCOS model-insulin resistance in experi-
mental animals showed a significant increase ac-
cretion of body weight compared to the normal 
control group (P < 0.05). In addition, only Mor-
inga oleifera leaf extract group 500 mg/kgBW 
significantly decreased accretion of body weight 
compared to the PCOS-insulin resistance control 
group (P < 0.05) (Table 1). 
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3.2. Effect of Treatment on Serum Insulin Pa-
rameters 
The PCOS model-insulin resistance in experi-
mental animals that was injected with testosterone 
propionate for 28 days showed a significant in-
crease in insulin levels compared to the normal 
control group (P < 0.05). In contrast, there was no 
statistically significant of the serum insulin levels 
between group with metformin and Moringa 
oleifera leaf extract treatment and the normal con-
trol group. In addition, Moringa oleifera leaf ex-
tract group 250 mg/kgBW, 500 mg/kgBW, and 
metformin significantly decreased insulin-level 
reduction compared to the PCOS-insulin resistance 
control group (P < 0.05) (Table 2).  
3.3. Effect of Treatment on Histological Pa-
rameters 
Histopathological examination after induction 
with testosterone propionate to PCOS-insulin re-
sistance showed the decreased of folliculogenesis 
compared to the normal control group based on the 
(A)            
 (B)          
Fig. (1). (A) The Graphs Characteristics of vaginal swab study data prior to treatment; (B) The Graphs Characteristics of vagi-
nal swab study data after treatment. 
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number (P < 0.05) and diameter (P < 0.05) of the 
de Graaf follicles. In addition, an overview of the 
histology of ovarian follicles of the PCOS control 
group-insulin resistance (Fig. 2B) showed that 
number follicular atresia was higher compared to 
the normal control group still has the de Graaf fol-
licles (Fig. 2A). Thus, the treatment with met-
formin and extract of Moringa oleifera leaf 
showed a significantly increased folliculogenesis 
in both number and diameter of the de Graaf folli-
cles in PCOS-insulin-sensitive female rat com-
pared to the PCOS-insulin resistance control group 
(Table 3). The treatment with metformin and ex-
tract of Moringa oleifera leaf did not show signifi-
cant differences in folliculogenesis with normal 
control groups. This could be seen from the ovar-
ian histologic features of the ovaries in the treat-
ment of metformin that indicating there were pri-
mary, secondary, and tertiary follicles (Fig. 2C)
but, the treatment with Moringa oleifera at a dose 
of 250mg/kgBW and 500mg/kgBW provides bet-
ter histologic features indicated by many primary 
follicles, secondary, tertiary, and de Graaf (Figs. 
2D and 2E).  
4. DISCUSSION 
In our study, the comparisons between normal 
control group and the PCOS-control group of the 
body weight was shown a significant difference. 
The PCOS-control group has a significant increase 
body weight (p <0.05) compared to normal control 
group which may be due to deposition of fat in the 
abdominal region and insulin resistance. Treat-
ment of Moringa oleifera leaf extract dose 250 
mg/kgBW and 500 mg/kgBW produced decrease 
in body weight, but only Moringa oleifera leaf ex-
tract dose 500 mg/kgBW that showed a signifi-
cantly decreased body weight compared to PCOS-
control group. The body weight decrease because 
of the quercetin in Moringa oleifera has been re-
ported to be useful in redistribution and uptake of 
fat and reported to be used in obesity [17]. Mean-
while, treatment with metformin has a significant 
increase body weight (p <0.05) compared to nor-
mal control group. Metformin is the first line of 
PCOS obese treatment by inhibiting hepatic glu-
cose absorption, increasing peripheral glucose up-
take, reducing peripheral insulin levels, and im-
proving GLUT-4 [7]. Metformin has an effect on 
the endothelium and adipose tissue independent of 
its action on insulin and glucose levels [18]. Based 
on the evidence, metformin does not help to body 
weight loss although it may be useful in redistrib-
uting adipose tissue [19]. 
We determined an insulin resistance condition 
in the PCOS model. Then, the comparisons be-
tween normal and the PCOS-control group of insu-
lin resistance was showed a significant difference. 
The PCOS model-insulin resistance in female rats 
injected with 1 mg/100gBW intra-muscular testos-
terone for 28 days increased the insulin levels as 
evidenced by a significant increase in insulin lev-
Table 1. Effect of treatment on physical parameter. 
- K1 K2 K3 K4 K5 
Accretion of body weight after the 
treatment 
(gram) 
58.75±14.17 74±18.28a 77±12.17a 66.25±8.21 55.62±6.32b
asignificantly different from normal control (p <0.05) 
bsignificantly different from PCOS control-insulin resistance (p <0.05) 
K1: normal control group; K2: PCOS insulin resistance control group; K3: PCOS insulin resistance metformin group; K4: PCOS insulin resistance Moringa 
oleifera leaf extract 250mg/KgBW group; K5: PCOS insulin resistance Moringa oleifera leaf extract 500mg/KgBW group. 
Table 2. Effect of treatment on serum insulin parameter. 
- K1 K2 K3 K4 K5 
Insulin (ng/mL) 12.92±1.42 16.91±3.75a 13.32±2.04b 11.79±1.26b 13.8±3.02b
asignificantly different from normal control (p <0.05) 
bsignificantly different from PCOS control-insulin resistance (p <0.05) 
K1: normal control group; K2: PCOS insulin resistance control group; K3: PCOS insulin resistance metformin group; K4: PCOS insulin resistance Moringa 
oleifera leaf extract 250mg/KgBW group; K5: PCOS insulin resistance Moringa oleifera leaf extract 500mg/KgBW group. 
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els (p <0.05) in the PCOS-control group of insulin 
resistance compared with normal control group. 
Additionally, the androgens directly inhibit the 
action of insulin in the periphery, in the liver, and 
androgen that indirectly also affects the insulin 
sensitivity by altering body composition through 
the fat metabolism [20]. Androgens (testosterone) 
cause the insulin resistance by decreasing the 
amount and effectiveness of glucose transport pro-
teins, especially GLUT-4 which was the responsi-
     
                                                A             B 
      
C             D 
E
Fig. (2). The Histology of ovarian follicles: (A) normal control group; (B) PCOS control group-insulin resistance; (C) PCOS 
group-insulin resistance given metformin treatment; (D) PCOS group-insulin resistance was given extract of treatment 
Moringa oleifera 250 mg/kgBW; (E) PCOS group-insulin resistance given extract of treatment Moringa oleifera 500 
mg/kgBW. 
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ble for the transport of glucose in muscle and fat. 
Testosterone facilitates lipolysis and breakdown of 
abdominal fat, leading to an increase in free fatty 
acids. Increased androgens and free fatty acids in-
hibit the excretion of insulin in the liver and trans-
port of glucose in the muscle, eventually leading to 
hyperinsulinemia and insulin resistance [21, 22]. 
Furthermore, the Moringa oleifera leaf extract 
could lower the insulin levels in PCOS models 
with insulin resistance. The normal control group 
of Moringa oleifera leaf extract's dose was 
250mg/kgBW and 500mg/kgBW and metformin 
group for 14 days in female rat of PCOS-insulin 
resistance model that showed no significant differ-
ence. This suggests that Moringa oleifera and met-
formin were equally good at lowering insulin lev-
els in the normal control group. Moringa oleifera
leaf extract group of 250 mg/kgBW and 500 
mg/kgBW and metformin group showed signifi-
cantly lower insulin levels than the PCOS control 
group-insulin resistance. This suggests that ad-
ministration of Moringa oleifera leaf extract and 
metformin decrease the insulin levels in the female 
rat of PCOS-insulin resistance. 
Flavonol quercetin was found with high con-
centrations in Moringa oleifera leaves [10]. Quer-
cetin was one of the flavonoids possessing a strong 
bioactive element with the effects of free radicals, 
anti-inflammation, anticancer, antihyperlipidemic, 
and antiplatelet [12]. Recent studies suggest quer-
cetin was also found to produce PI3K inhibin [13]. 
Quercetin has the potential to directly influence 
the target pathway of steroidogenesis in ovarian 
through cells of the PI3K inhibitor, decreasing the 
expression of CYP17A1 gene in theca cells re-
sponsible for decreasing the activation of 17a-
hydroxylase. This decrease of 17a-hydroxylase 
activation plays a role in the synthesis of steroids 
by decreasing the conversion of progesterone to 
androgens thereby decreasing androgen levels [1]. 
Additionally, through the PI3K pathway, it could 
phosphorylate the Akt protein so that when acti-
vated Akt protein plays an important role in the 
GLUT4 and FOXO1 molecules [23]. 
Glucose transporter type 4 (GLUT-4) was a 
transport protein for glucose that aims to bring 
glucose into cells. The GLUT-4 translocation 
process to the target cell surface begins with insu-
lin bonding and the  subunit insulin receptor 
wherein the bond causes the  subunit of the insu-
lin receptor and the other subunit IRS-1 to auto-
phosphorylation. IRS-1 further activates the PI3K 
mediating GLUT-4 translocation to the surface of 
the target cell [14]. Increased translocation of 
GLUT-4 causes uptake of glucose from extra cells 
into intra-cell also increases. Increased glucose 
uptake improves insulin resistance conditions. 
PCOS model-insulin resistance performed in 
female rats has occurred insulin resistance by de-
creasing folliculogenesis. The decreased of follicu-
logenesis in female rats as evidenced by the num-
ber and diameter of de Graaf follicles in the nor-
mal control group compared the PCOS-insulin re-
sistance group show that a significant difference (p 
<0.05). 
Insulin resistance leads to hyperinsulinemia 
compensation then increased androgen production 
in the ovaries by increasing GnRH frequency and 
LH pulsation secretion [1]. Decreased steroi-
dogenesis in ovarian tissue through insulin and LH 
work directly increases intracellular cAMP con-
centrations by activating StAR which has the po-
tential for direct action of steroidogenesis by de-
creasing PI3K path activity. Insulin and LH also 
work directly to increase transcription of LDL-C 
receptors in ovarian granulosa cells through in-
creased activity on PKA and MAPK pathways and 
decreased PI3K. In addition, insulin also improves 
the regulation of aromatization in ovarian granu-
Table 3. Effect of treatment on histological parameters. 
- K1 K2 K3 K4 K5 
Number Follicles 3.37±1.68 0.00±0.00a 3.25±1.49b 4.5±1.6b 3.75±1.49b
Diameter follicles 61.44±3.9 0.00±0.00a 52.97±10.86b 67.1±12.0b 56.22±6.26b
asignificantly different from normal control (p <0.05) 
bsignificantly different from PCOS control-insulin resistance (p <0.05) 
K1: normal control group; K2: PCOS insulin resistance control group; K3: PCOS insulin resistance metformin group; K4: PCOS insulin resistance Moringa 
oleifera leaf extract 250mg/KgBW group; K5: PCOS insulin resistance Moringa oleifera leaf extract 500mg/KgBW group. 
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losa cells resulting in increased androgen produc-
tion in the ovarian cell [1]. This hyperandrogenic 
state results in the internal environment of the fol-
licle being so dominant androgen that it could not 
develop and become atresia [24]. 
Giving Moringa oleifera leaf extract could in-
crease folliculogenesis in ovary model of PCOS 
with insulin resistance. Normal control group 
compared treatment group extract of Moringa 
oleifera leaf dose 250 mg/kgBW and 500 
mg/kgBW and metformin group show that no sig-
nificant difference. This suggests that Moringa 
oleifera and metformin might increase the near 
normal folliculogenesis after being given a PCOS 
model-insulin resistance comparable to the normal 
control group. Treatment of Moringa oleifera leaf 
extract dose 250 mg/kgBW and 500 mg/kgBW 
and metformin group significantly increased fol-
liculogenesis compared to PCOS-insulin resistance 
control group. This suggests that Moringa oleifera
and metformin were equally good at increasing 
folliculogenesis in female PCOS-insulin-resistance 
rats. 
Decreased insulin levels in peripheral tissue 
will lead to decrease androgen production in the 
ovaries. Decreased insulin levels and IGF-1 indi-
rectly also could decrease androgen levels by in-
creasing SHBG production in the liver and in-
crease the synthesis of IGFBP-1 directly, quickly, 
and complete both in the liver also ovaries so that 
the levels of IGF-I, IGF-II, and free testosterone 
decreases [1]. This androgen decline will affect the 
environment of the ovaries, androgen aromatiza-
tion system disorders into estrogen that triggers the 
absence of early follicular infestation. The de-
crease in insulin resistance decreases the fre-
quency of GnRH and LH pulsation secretion re-
sulting in an increase in folliculogenesis (early 
atresia does not occur).  
In conclusion, Moringa oleifera could reduce 
the blood insulin levels, subsequently decreasing 
the androgen thus allowed the increasing of fol-
liculogenesis in the model of female rat PCOS-
insulin resistance. 
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